Elevation Oncology, Inc.
ELEV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $32 | $18 | $22 | $140 |
| - Cash | $49 | $49 | $46 | $146 |
| + Debt | $31 | $30 | $29 | $0 |
| Enterprise Value | $14 | -$1 | $6 | -$7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$45 | -$41 | -$95 | -$32 |
| % Margin | – | – | – | – |
| Net Income | -$44 | -$46 | -$95 | -$32 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.78 | -1.34 | -4.09 | -1.38 |
| % Growth | 41.8% | 67.2% | -196.4% | – |
| Operating Cash Flow | -$36 | -$56 | -$85 | -$30 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$36 | -$56 | -$86 | -$30 |